Effects of different systemic contraceptives on blood fibrinolysis.
D000328:Adult; D000463:Algestone Acetophenide / Q000009:adverse effects; D001780:Blood Coagulation Tests; D003276:Contraceptives, Oral / Q000009:adverse effects*; D004958:Estradiol / Q000009:adverse effects*; D004997:Ethinyl Estradiol / Q000009:adverse effects*; D005040:Ethynodiol Diacetate / Q000009:adverse effects*; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D008525:Medroxyprogesterone / Q000009:adverse effects*; D008656:Mestranol / Q000009:adverse effects*; D008875:Middle Aged; D009640:Norethindrone / Q000009:adverse effects*; D009641:Norethynodrel / Q000009:adverse effects*; D010958:Plasminogen / Q000032:analysis; D011247:Pregnancy; D011278:Pregnanes / Q000009:adverse effects*; D011372:Progestins / Q000009:adverse effects*
D003276:Contraceptives, Oral; D011278:Pregnanes; D011372:Progestins; D004997:Ethinyl Estradiol; D004958:Estradiol; D005040:Ethynodiol Diacetate; D009641:Norethynodrel; D005340:Fibrinogen; D010958:Plasminogen; D008656:Mestranol; D008525:Medroxyprogesterone; D000463:Algestone Acetophenide; D009640:Norethindrone